|
SourceOne Stock Info Your one source site for
stock research |
||||||||||||
Investor RelationsWhat’s the buzz— message boards |
Celgene
Corporation
CELG Celgene Corporation is a biopharmaceutical company chiefly engaged in the research, development and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases. Celgene has ongoing development of immunomodulatory drugs, cell-signaling inhibitors, as well as cellular and tissue therapeutics. Celgene's commercial programs include pharmaceutical sales of THALOMID and ALKERAN, a licensing agreement with Novartis for FOCALIN and the entire RITALIN family of drugs and biotherapeutic products and services, including BIOVANCE, LIFEBANK and AMBIODRY through Celgene Cellular Therapeutics. Stock Quotes and Other InformationSearch
for Stocks: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Alphabetical
Listings by Company Name S&P
100 S&P
500 S&P
400 Dow Jones
Industrials Dow Jones Transportation Dow Jones
Utilities Dow Jones Composite Nasdaq 100 Morgan Stanley Hi-Tech 35 |
|
||||||||||